您的位置: 首页 > 农业专利 > 详情页

PIRAZOLSKI DERIVATI KAO MODULATORI KALCIJEVIH KANALA AKTIVIRANIH OSLOBAĐANJEM KALCIJA
专利权人:
Rhizen Pharmaceuticals S.A.
发明人:
Muthuppalaniappan, Meyyappan,Viswanadha, Srikant,Merikapudi, Gayatri, Swaroop,Vakkalanka, Swaroop, Kumar, V.S.,Vakkalanka,
申请号:
HRP20181076
公开号:
HRP20181076T1
申请日:
2018.07.10
申请国别(地区):
HR
年份:
2018
代理人:
摘要:
Disclosed are novel calcium release-activated calcium (CRAC) channel inhibitors, methods for preparing them, pharmaceutical compositions containing them, and methods of treatment using them. The present disclosure also relates to methods for treating non-small cell lung cancer (NSCLC) with CRAC inhibitors, and to methods for identifying therapeutics for treating and of diagnosing cancer.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充